Last reviewed · How we verify
Treatment with intravenous iron
Treatment with intravenous iron is a Small molecule drug developed by University of Rochester. It is currently FDA-approved.
At a glance
| Generic name | Treatment with intravenous iron |
|---|---|
| Sponsor | University of Rochester |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Iron and Immune Response to Vaccine (IRONMUM) (NA)
- Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome (PHASE4)
- Patient Blood Management in Cardiac Surgery (NA)
- A Phase 1 Study of PVT401 in Healthy Subjects (PHASE1)
- Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation (PHASE4)
- Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency (PHASE3)
- An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function (NA)
- The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Treatment with intravenous iron CI brief — competitive landscape report
- Treatment with intravenous iron updates RSS · CI watch RSS
- University of Rochester portfolio CI
Frequently asked questions about Treatment with intravenous iron
What is Treatment with intravenous iron?
Treatment with intravenous iron is a Small molecule drug developed by University of Rochester.
Who makes Treatment with intravenous iron?
Treatment with intravenous iron is developed and marketed by University of Rochester (see full University of Rochester pipeline at /company/university-of-rochester).
What development phase is Treatment with intravenous iron in?
Treatment with intravenous iron is FDA-approved (marketed).